These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38713861)

  • 41. Genetic engineering of T cell specificity for immunotherapy of cancer.
    Willemsen RA; Debets R; Chames P; Bolhuis RL
    Hum Immunol; 2003 Jan; 64(1):56-68. PubMed ID: 12507815
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Single-Cell TCR and Transcriptome Analysis: An Indispensable Tool for Studying T-Cell Biology and Cancer Immunotherapy.
    Pasetto A; Lu YC
    Front Immunol; 2021; 12():689091. PubMed ID: 34163487
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Identification of the cognate peptide-MHC target of T cell receptors using molecular modeling and force field scoring.
    Lanzarotti E; Marcatili P; Nielsen M
    Mol Immunol; 2018 Feb; 94():91-97. PubMed ID: 29288899
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Propedia: a database for protein-peptide identification based on a hybrid clustering algorithm.
    Martins PM; Santos LH; Mariano D; Queiroz FC; Bastos LL; Gomes IS; Fischer PHC; Rocha REO; Silveira SA; de Lima LHF; de Magalhães MTQ; Oliveira MGA; de Melo-Minardi RC
    BMC Bioinformatics; 2021 Jan; 22(1):1. PubMed ID: 33388027
    [TBL] [Abstract][Full Text] [Related]  

  • 45. MechanoProDB: a web-based database for exploring the mechanical properties of proteins.
    Mesbah I; Habermann B; Rico F
    Database (Oxford); 2024 Jun; 2024():. PubMed ID: 38837788
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chimeric T-cell receptors: new challenges for targeted immunotherapy in hematologic malignancies.
    Biagi E; Marin V; Giordano Attianese GM; Dander E; D'Amico G; Biondi A
    Haematologica; 2007 Mar; 92(3):381-8. PubMed ID: 17339188
    [TBL] [Abstract][Full Text] [Related]  

  • 47. CrossDome: an interactive R package to predict cross-reactivity risk using immunopeptidomics databases.
    Fonseca AF; Antunes DA
    Front Immunol; 2023; 14():1142573. PubMed ID: 37377956
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Rapid Construction of Antitumor T-cell Receptor Vectors from Frozen Tumors for Engineered T-cell Therapy.
    Tsuji T; Yoneda A; Matsuzaki J; Miliotto A; Ryan C; Koya RC; Odunsi K
    Cancer Immunol Res; 2018 May; 6(5):594-604. PubMed ID: 29588318
    [TBL] [Abstract][Full Text] [Related]  

  • 49. epiTCR: a highly sensitive predictor for TCR-peptide binding.
    Pham MN; Nguyen TN; Tran LS; Nguyen QB; Nguyen TH; Pham TMQ; Nguyen HN; Giang H; Phan MD; Nguyen V
    Bioinformatics; 2023 May; 39(5):. PubMed ID: 37094220
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The Promise of Personalized TCR-Based Cellular Immunotherapy for Cancer Patients.
    Arnaud M; Bobisse S; Chiffelle J; Harari A
    Front Immunol; 2021; 12():701636. PubMed ID: 34394096
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of Patients With Metastatic Cancer Using a Major Histocompatibility Complex Class II-Restricted T-Cell Receptor Targeting the Cancer Germline Antigen MAGE-A3.
    Lu YC; Parker LL; Lu T; Zheng Z; Toomey MA; White DE; Yao X; Li YF; Robbins PF; Feldman SA; van der Bruggen P; Klebanoff CA; Goff SL; Sherry RM; Kammula US; Yang JC; Rosenberg SA
    J Clin Oncol; 2017 Oct; 35(29):3322-3329. PubMed ID: 28809608
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The immune checkpoint receptor LAG3: Structure, function, and target for cancer immunotherapy.
    Mariuzza RA; Shahid S; Karade SS
    J Biol Chem; 2024 May; 300(5):107241. PubMed ID: 38556085
    [TBL] [Abstract][Full Text] [Related]  

  • 53. TCR repertoires of intratumoral T-cell subsets.
    Linnemann C; Mezzadra R; Schumacher TN
    Immunol Rev; 2014 Jan; 257(1):72-82. PubMed ID: 24329790
    [TBL] [Abstract][Full Text] [Related]  

  • 54. LiqBioer: a manually curated database of cancer biomarkers in body fluid.
    Geng Y; Jin L; Tang G; Zhao Z; Gu Y; Yang D
    Database (Oxford); 2022 Sep; 2022():. PubMed ID: 36053554
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 56. IMGT, the international ImMunoGeneTics database.
    Giudicelli V; Chaume D; Bodmer J; Müller W; Busin C; Marsh S; Bontrop R; Marc L; Malik A; Lefranc MP
    Nucleic Acids Res; 1997 Jan; 25(1):206-11. PubMed ID: 9016537
    [TBL] [Abstract][Full Text] [Related]  

  • 57. PDTD: a web-accessible protein database for drug target identification.
    Gao Z; Li H; Zhang H; Liu X; Kang L; Luo X; Zhu W; Chen K; Wang X; Jiang H
    BMC Bioinformatics; 2008 Feb; 9():104. PubMed ID: 18282303
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Predicting CD4 T-cell epitopes based on antigen cleavage, MHCII presentation, and TCR recognition.
    Schneidman-Duhovny D; Khuri N; Dong GQ; Winter MB; Shifrut E; Friedman N; Craik CS; Pratt KP; Paz P; Aswad F; Sali A
    PLoS One; 2018; 13(11):e0206654. PubMed ID: 30399156
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cancer immunotherapy utilizing gene-modified T cells: From the bench to the clinic.
    Duong CP; Yong CS; Kershaw MH; Slaney CY; Darcy PK
    Mol Immunol; 2015 Oct; 67(2 Pt A):46-57. PubMed ID: 25595028
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Investigation of Antigen-Specific T-Cell Receptor Clusters in Human Cancers.
    Zhang H; Liu L; Zhang J; Chen J; Ye J; Shukla S; Qiao J; Zhan X; Chen H; Wu CJ; Fu YX; Li B
    Clin Cancer Res; 2020 Mar; 26(6):1359-1371. PubMed ID: 31831563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.